Details for 2018183272

Up to date per 01.04.2026

Actions

Title / Product Name

REDUZIERUNG DER IMMUNOGENITÄT GEGEN DEN FAKTOR VIII BEI PATIENTEN IN EINER FAKTOR-VIII-THERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018183272

EP Publication Number

3453402

E-Number

1411976

Language

PCT Number

Publication Date

13.03.2019 A

21.07.2021 B1

Registration Date

21.07.2021

AT Publication Date

15.08.2021

Application Date

12.01.2013

Registration Number

Priorities

12.01.2012

201261586103 P

06.07.2012

201261668961 P

IPC

A61K 38/21 20060101AFI20201218BHEP

Maximum Duration of Protection

12.01.2033

Owner

Bioverativ Therapeutics Inc.225 Second Avenue Waltham MA 02451US

Puget Sound Blood Center921 Terry Avenue Seattle, Washington 98104-1256US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

JIANG, Haiyan3 Bayberry Lane Belmont, MA Massachusetts 02478US

LIU, Tongyao53 Buckman Drive Lexington, MA Massachusetts 02421US

KRISHNAMOORTHY, Sriram7 Martha Lane Acton, MA Massachusetts 01720US

JOSEPHSON, NeilPuget Sound Blood Center 921 Terry Ave Seattle, WA Washington 98104-1256US

GLENN, Pierce14 Cambridge Center Cambridge, MA Massachusetts 02142US

Information about Fees